Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biomerieux SA
0RUGCurrent price
108.95 EUR
0 EUR (0.00%)
Last closed
110.2 EUR
Company
www.biomerieux.com
ISIN
FR0013280286
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
London Exchange
Capitalization
12 993 716 028 EUR
Yield for 12 month
+21.16 %
1Y
3Y
5Y
10Y
15Y
0RUG
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA. Address: 376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
104.21 EURP/E ratio
31.7579Dividend Yield
0.77 %Current Year
+3 671 720 421 EUR
Last Year
+3 586 189 828 EUR
Current Quarter
+1 900 357 871 EUR
Last Quarter
+1 903 055 682 EUR
Current Year
+1 885 170 195 EUR
Last Year
+1 959 509 869 EUR
Current Quarter
+1 044 252 595 EUR
Last Quarter
+970 312 597 EUR
Key Figures 0RUG
1 year
3 years
5 years
10 years
EBITDA
862 799 875 EUR
Operating Margin TTM
PE Ratio
31.7579
Return On Assets TTM
7.08 %
PEG Ratio
2.9045
Return On Equity TTM
10.61 %
Wall Street Target Price
104.21 EUR
Revenue TTM
3 803 413 648 EUR
Book Value
32.75 EUR
Revenue Per Share TTM
Dividend Share
0.85 EUR
Quarterly Revenue Growth YOY
7.4 %
Dividend Yield
0.77 %
Gross Profit TTM
2 007 071 273 EUR
Earnings per share
3.47 EUR
Diluted Eps TTM
3.47 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
34.1 %
Profit Margin
10.81 %
Dividend Analytics 0RUG
Dividend growth over 5 years
150 %Continuous growth
–Payout Ratio 5 years average
17 %Dividend History 0RUG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.85
Ex Dividend Date
07.06.2024
Forward Annual Dividend Yield
0.77 %
Last Split Factor
3:1
Payout Ratio
24.5 %
Last Split Date
20.09.2017
Dividend Date
–
Stock Valuation 0RUG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
31.7579
Forward PE
24.3902
Enterprise Value Revenue
3.4948
Price Sales TTM
3.4163
Enterprise Value EBITDA
18.3077
Price Book MRQ
3.3652
Financials 0RUG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0RUG
For 52 weeks
83.72 EUR
111.41 EUR
50 Day MA
97.93 EUR
Shares Short Prior Month
–
200 Day MA
98.6 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart